• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Bigmet FC 500 mg is indicated for:
Management of type 2 diabetes mellitus when diet and exercise alone are insufficient
Used as initial therapy or add-on to other antidiabetic agents
Helps improve glycemic control by complementary mechanisms
Bigmet FC combines:
Metformin Hydrochloride, which decreases hepatic glucose production and improves peripheral insulin sensitivity.
Sitagliptin Phosphate, a DPP-4 inhibitor that enhances incretin hormone levels, increasing insulin release and decreasing glucagon secretion.
Typically, 1 tablet twice daily with meals or as prescribed by the physician
Dosage adjusted based on glycemic response and tolerance
Take orally with food to minimize gastrointestinal side effects.
Alcohol increases risk of lactic acidosis with Metformin
Possible interactions with drugs affecting renal function or glucose metabolism
Caution with other antidiabetic agents to avoid hypoglycemia
Severe renal impairment (eGFR <30 ml/min/1.73 m²)
Diabetic ketoacidosis or metabolic acidosis
Hypersensitivity to Metformin, Sitagliptin, or excipients
Gastrointestinal symptoms: nausea, diarrhea, abdominal discomfort
Rare but serious: lactic acidosis, pancreatitis
Possible headache, upper respiratory tract infection
Use only if clearly needed and prescribed
Consult physician before use during pregnancy or breastfeeding
Monitor renal function periodically
Discontinue before iodinated contrast procedures
Use cautiously in elderly and those with cardiovascular disease
Oral Antidiabetic Combination (Biguanide + DPP-4 inhibitor)
Store below 25°C
Protect from moisture and light
Keep out of reach of children